Advertisement

Implantable loop recorders in Brugada syndrome: An ally?

Published:October 17, 2021DOI:https://doi.org/10.1016/j.hrthm.2021.10.011
      Although most patients with Brugada syndrome (BrS) will remain asymptomatic during follow-up, some may die suddenly or have recurrent malignant ventricular arrhythmias (VAs). Accurate arrhythmic risk stratification is of utmost importance, but unfortunately it remains challenging, except for patients who have survived an episode of sudden cardiac death, those who need to be treated with an implantable cardiac defibrillator (ICD), and in asymptomatic patients in whom a type 1 electrocardiographic (ECG) pattern (ie, leads V1 and V2 positioned in second, third, and/or fourth intercostal spaces) is documented only after the administration of a sodium channel blocker, where regular follow-up is recommended without the need for ICD implantation.
      • Al-Khatib S.M.
      • Stevenson W.G.
      • Ackerman M.J.
      • et al.
      2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Al-Khatib S.M.
        • Stevenson W.G.
        • Ackerman M.J.
        • et al.
        2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
        Heart Rhythm. 2018; 15: e73-e189
        • Eckardt L.
        • Probst V.
        • Smits J.P.P.
        • et al.
        Long-term prognosis of individuals with right precordial ST-segment–elevation Brugada syndrome.
        Circulation. 2005; 111: 257-263
        • Hernandez-Ojeda J.
        • Arbelo E.
        • Jorda P.
        • et al.
        The role of clinical assessment and electrophysiology study in Brugada syndrome patients with syncope.
        Am Heart J. 2020; 220: 213-223
        • Delise P.
        • Allocca G.
        • Marras E.
        • et al.
        Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.
        Eur Heart J. 2011; 32: 169-176
        • Rodríguez-Mañero M.
        • Baluja A.
        • Hernández J.
        • et al.
        Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study.
        Rev Esp Cardiol (Engl Ed). 2021; (XX:XX–XX)
        • Scrocco C.
        • Ben-Haim Y.
        • Devine B.
        • et al.
        Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: a United Kingdom single-center experience.
        Heart Rhythm. 2021; (XX:XX–XX)
        • Kewcharoen J.
        • Rattanawong P.
        • Kanitsoraphan C.
        • et al.
        Atrial fibrillation and risk of major arrhythmic events in Brugada syndrome: a meta-analysis.
        Ann Noninvasive Electrocardiol. 2019; 24e12676
        • Antzelevitch C.
        • Yan G.-X.
        • Ackerman M.J.
        • et al.
        J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge.
        Heart Rhythm. 2016; 13: e295-e324
        • Sroubek J.
        • Probst V.
        • Mazzanti A.
        • et al.
        Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis.
        Circulation. 2016; 133: 622-630

      Linked Article